Detalles de la búsqueda
1.
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study.
Ann Oncol
; 21(11): 2233-2239, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20444843
2.
Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer.
Ann Oncol
; 20(9): 1565-1575, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19487488
3.
Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.
J Natl Cancer Inst
; 84(23): 1816-20, 1992 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-1331485
4.
Assessment of biological activity of linear alpha-transforming growth factor and monospecific antibodies to alpha-transforming growth factor and linear alpha-transforming growth factor.
Cancer Res
; 46(11): 5567-70, 1986 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-3463415
5.
Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Cancer Res
; 53(16): 3747-51, 1993 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8339286
6.
Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
Cancer Res
; 48(17): 5023-8, 1988 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-3165707
7.
Phase I clinical trial of carbetimer.
Cancer Res
; 48(18): 5353-7, 1988 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-2842047
8.
Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation.
Biochim Biophys Acta
; 1221(2): 115-24, 1994 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-8148388
9.
Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin.
J Clin Oncol
; 17(10): 3009-16, 1999 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-10506594
10.
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors.
J Clin Oncol
; 18(14): 2772-9, 2000 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-10894878
11.
Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.
J Clin Oncol
; 19(4): 1167-75, 2001 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11181683
12.
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
Clin Cancer Res
; 6(5): 1736-43, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10815892
13.
Effects of recombinant human interleukin-1 alpha on clonogenic growth of primary human tumors in vitro.
J Immunother (1991)
; 11(3): 155-8, 1992 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-1515420
14.
Evidence for binding of extrachromosomal DNA sequences to nuclear matrix proteins in multidrug-resistant KB-V1 cells.
FEBS Lett
; 319(1-2): 133-7, 1993 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8454045
15.
Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication.
FEBS Lett
; 366(2-3): 92-8, 1995 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-7789538
16.
The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.
Curr Pharm Des
; 10(16): 1923-36, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15180529
17.
Effects of the microtubule-disturbing agents docetaxel (Taxotere), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro.
Eur J Cancer
; 30A(11): 1688-94, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7833145
18.
In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.
Eur J Cancer
; 29A(3): 423-5, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8398345
19.
Preclinical activity of 17 beta-[N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-L-alanyl]-5 alpha-dihydrotestosterone (E91) against tumour colony forming units and haematopoietic progenitor cells.
Eur J Cancer
; 35(6): 1009-13, 1999 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10533486
20.
Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro.
Eur J Cancer
; 31A(10): 1677-81, 1995 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-7488424